Lintlha tse ling ― Sesotho

Urticaria hangata e hlahisa li‑welts tse tsoang matsohong a hlohloneng haholo. Ka linako tse ling e ka ba le lefu le ruruha la lisele tse ka tlaase. Kalafo e kholo‑holo e kenyelletsa ho qoba lintho tse bakang mathata, haeba li tsejoa. Meriana ea pele e kenyelletsa li‑antihistamine tse ncha, tse ka fetoloang ho litekanyetso tse phahameng ha ho hlokahala. Meriana e meng e kang li‑antihistamine tsa khale, li‑H2 blockers, li‑leukotriene receptor antagonists, li‑antihistamine tse matla, le litholoana tsa corticosteroids tse khutšoanyane li ka eketsoa e le tšehetso e eketsehileng. Ha urticaria e phehella ho sa tsotellehe mehato ena, bakuli ba ka 'na ba isoa ho litsebi bakeng sa liphekolo tse eketsehileng tse kang omalizumab kapa cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Tlhahlobo ena e fana ka tataiso ea morao‑rao bakeng sa phekolo ea urticaria le ho fana ka kutloisiso e ncha mabapi le lisosa tsa eona.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids